IRADIMED CORPORATION
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $499.8K | $7.2M | $7.5M | $2.1M | $1.9M |
| Depreciation & Amortization | $1.3M | $955.8K | $807.3K | $149.1K | $139.0K |
| Depreciation | $362.9K | $230.3K | $187.9K | $110.6K | $101.4K |
| Amortization | $82.4K | $18.0K | $36.0K | $38.5K | $37.6K |
| Stock-Based Compensation | $2.5M | $1.8M | $1.2M | $724.1K | $271.9K |
| Net Cash from Operating Activities | $3.4M | $9.4M | $7.6M | $2.6M | $1.5M |
| Investing Activities | |||||
| Capital Expenditures | $775.6K | $780.8K | $298.7K | $584.0K | $163.2K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.0M | $-1.9M | $-61.5K | $-8.3M | $-196.7K |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | $1.8M | $10.0M | — | — | — |
| Net Cash from Financing Activities | $-1.9M | $-9.1M | $2.3M | — | — |
| Net Change in Cash | $492.1K | $-1.7M | $9.9M | — | — |
| Free Cash Flow | $2.6M | $8.6M | $7.4M | $2.0M | $1.3M |